More articles from Clinical Investigation

You have access
Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J. Larsen, Jan Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner and Michael Wagner

Journal of Nuclear Medicine May 1, 2022, 63 (5) 794-800; DOI: https://doi.org/10.2967/jnumed.121.262506
You have access
Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
Justin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, Manuel Weber, Nader Hirmas, Karina Kostbade, Sebastian Bauer, Martin Schuler, Marit Ahrens, Hans-Ulrich Schildhaus, Christoph Rischpler, Hong Grafe, Jens T. Siveke, Ken Herrmann, Wolfgang P. Fendler and Rainer Hamacher

Journal of Nuclear Medicine May 1, 2022, 63 (5) 727-734; DOI: https://doi.org/10.2967/jnumed.121.262468
You have access
Biodistribution of ¹⁸F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader
Ramsha Iqbal, Maqsood Yaqub, Daniela E. Oprea-Lager, Yeukman Liu, Anne Marije Luik, Andy P. Beelen, Robert C. Schuit, Albert D. Windhorst, Ronald Boellaard and Catharina W. Menke-van der Houven van Oordt

Journal of Nuclear Medicine May 1, 2022, 63 (5) 694-699; DOI: https://doi.org/10.2967/jnumed.121.262500
You have access
¹⁸F-4FMFES and ¹⁸F-FDG PET/CT in Estrogen Receptor–Positive Endometrial Carcinomas: Preliminary Report
Michel Paquette, Esteban Espinosa-Bentancourt, Éric Lavallée, Serge Phoenix, Korine Lapointe-Milot, Paul Bessette, Brigitte Guérin and Éric E. Turcotte

Journal of Nuclear Medicine May 1, 2022, 63 (5) 702-707; DOI: https://doi.org/10.2967/jnumed.121.262617
You have access
¹¹C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
Asim K. Bag, Melissa N. Wing, Noah D. Sabin, Scott N. Hwang, Gregory T. Armstrong, Yuanyuan Han, Yimei Li, Scott E. Snyder, Giles W. Robinson, Ibrahim Qaddoumi, Alberto Broniscer, John T. Lucas and Barry L. Shulkin

Journal of Nuclear Medicine May 1, 2022, 63 (5) 664-671; DOI: https://doi.org/10.2967/jnumed.120.261891
You have access
¹⁸F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
Joseph G. Crompton, Wesley R. Armstrong, Mark A. Eckardt, Ameen Seyedroudbari, William D. Tap, Sarah M. Dry, Evan R. Abt, Jeremie Calais, Ken Herrmann, Johannes Czernin, Fritz C. Eilber and Matthias R. Benz

Journal of Nuclear Medicine May 1, 2022, 63 (5) 708-712; DOI: https://doi.org/10.2967/jnumed.121.262502
You have access
⁹⁰Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study
Benedikt M. Schaarschmidt, Moritz Wildgruber, Roman Kloeckner, James Nie, Verena Steinle, Arthur J.A.T. Braat, Fabian Lohoefer, Hyun S. Kim, Harald Lahner, Manuel Weber and Jens Theysohn

Journal of Nuclear Medicine May 1, 2022, 63 (5) 679-685; DOI: https://doi.org/10.2967/jnumed.121.262561
Open Access
Epidermal Growth Factor Receptor–Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer
Jasper Vonk, Jaron G. de Wit, Floris J. Voskuil, Yang Hang Tang, Wouter T.R. Hooghiemstra, Matthijs D. Linssen, Evert van den Broek, Jan J. Doff, Sebastiaan A.H.J. de Visscher, Kees-Pieter Schepman, Bert van der Vegt, Gooitzen M. van Dam and Max J.H. Witjes

Journal of Nuclear Medicine May 1, 2022, 63 (5) 672-678; DOI: https://doi.org/10.2967/jnumed.121.262530
You have access
PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non–Small Cell Lung Cancer
Jasper Smit, Frank J. Borm, Anna-Larissa N. Niemeijer, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Daniela E. Oprea-Lager, Danielle J. Vugts, Guus A.M.S. van Dongen, Berlinda J. de Wit-van der Veen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen

Journal of Nuclear Medicine May 1, 2022, 63 (5) 686-693; DOI: https://doi.org/10.2967/jnumed.121.262473
You have access
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer
Erwin Woff, Lisa Salvatore, Federica Marmorino, Dario Genovesi, Gabriela Critchi, Thomas Guiot, Lieveke Ameye, Francesco Sclafani, Alain Hendlisz and Patrick Flamen

Journal of Nuclear Medicine April 1, 2022, 63 (4) 549-555; DOI: https://doi.org/10.2967/jnumed.120.245357

Main menu

User menu

Search

More articles from Clinical Investigation

Pages